Table 1.
Pre-operative imaging of fibrolamellar carcinoma
| Patient | Age (years)/sex | Imaging techniquesa | Size (cm) | Imaging featuresb | Lymphadenopathyc | Short axis (cm) | Metastasesd | Ascitese | Pre-operative treatmente |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 28/M | MRI | 12.6 | H | TP | 1.1 | 0 | Y | |
| 2 | 39/F | CT | 8.5 | TN | 0 | Y | |||
| 3 | 20/M | CT | 17.7 | H, C, S | TP | 4.9 | 0 | ||
| 4 | 34/M | CT + MRI | 9.3 | FN | 0 | ||||
| 5 | 17/M | CT + MRI | 11.9 | C, S | FP | 2.0 | 0 | ||
| 6 | 23/M | CT | 18.3 | V | TP | 3.5 | IH, Lu, per, Pleu | Y | |
| 7 | 20/F | CT | 13.2 | B, C, S | TP | 7.4 | 0 | Y | |
| 8 | 13/M | CT | 13.6 | FP | 1.5 | Lu | Y | Y | |
| 9 | 30/M | CT | 10.2 | B, C, S | TN | 0 | |||
| 10 | 20/M | CT | 15.9 | B C, S | TP | 4.2 | 0 | Y | |
| 11 | 17/F | CT | 6.2 | TN | 0 | ||||
| 12 | 15/F | CT | 7.6 | B, S | TP | 5.4 | Per | Y | Y |
| 13 | 24/M | CT + MRI | 17.0 | H, C, S | TN | 0 | |||
| 14 | 17/M | CT + MRI | 11.5 | C, S | FN | 0 | |||
| 15 | 16/F | MRI | 4.8 | C, S | TN | 0 | |||
| 16 | 18/F | CT | 11.7 | FN | 0 | ||||
| 17 | 18/M | CT | 14.0 | B | TP | 8.6 | IH | ||
| 18 | 19/F | CT + MRI | 6.1 | B | TP | 2.8 | 0 | Y | |
| 19 | 39/M | CT | 10.3 | TP | 2.5 | Per | |||
| 20 | 16/F | MRI | 11.9 | TN | Lu, per | ||||
| 21 | 27/F | MRI | 9.7 | TN | 0 | ||||
| 22 | 22/F | CT | 15.0 | V, S | TP | 4.2 | 0 | Y | |
| 23 | 14/F | CT + MRI | 12.3 | B | FP | 1.8 | 0 | ||
| 24 | 15/F | CT + MRI | 13.1 | B, C, S | TP | 2.3 | Lu |
F, female; M, male.
a
Imaging techniques include CT or MRI.
b
Imaging features assessed include biliary dilatation (B), haemorrhage (H), calcifications (C), scar (S) and gross vascular invasion (V).
c
Lymphadenopathy (LAD) was classified as true positives (TPs), true negatives (TNs), false positive (FP) or false negative (FN) based on our reference standard.
d
Metastases were either intrahepatic (IH) or found in the lungs (Lu), peritoneum (Per) or pleura (Pleu).
e
Ascites and pre-operative treatment was noted when present (Y = yes).